A Phase 3 interventional study of Active Effervescent Powder and Placebo Effervescent powder in Micronutrient Deficiencies, sponsored by InnoNext Sarl. Completed at 1 site in Ghana. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-14.
Sponsored by InnoNext Sarl · Phase 3, Interventional, and Prevention
Inadequate micronutrient status poses a significant challenge in Sub-Saharan African countries, including Ghana, and affects various demographics. The aim of the intervention study is to assess nutritional status and well-being through micronutrient supplementation with or without the combination of nutrition training and healthy lifestyle coaching among young adults in Ghana.
The outcomes the study is assessing are:
PRIMARY OUTCOME:
The primary outcome of this study is to determine if micronutrient supplement improves the vitamin D status of the study participants with or without additional Nutrition Training and Healthy Lifestyle Coaching. Vitamin D status will be assessed as serum 25(OH) D in serum.
SECONDARY OUTCOMES:
The secondary objectives are to:
TRIAL DESIGN: This study is a 3-arm blinded randomized placebo-controlled trial among 151 young adults
participants in Arm 1 receive a daily Investigational Product and attend nutrition training and healthy lifestyle coaching;
participants in Arm 2 will receive an active Investigational Product;
participants in Arm 3 will receive a placebo Investigational Product.
Main data collection, including blood sampling for nutritional status will take place at Baseline (Day 0), Midpoint (Month 3) and Endpoint (Month 6). In addition, all participants will fill in a digital diary.
This study is a 6-month intervention study to assess the effect of micronutrient supplementation in combination with healthy lifestyle coaching on nutrition status and well-being will improve nutritional status with or without the combination of nutrition training and healthy lifestyle coaching among young adults in Ghana.
The test product is an Effervescent powder that is Orange flavored containing multiple vitamins and minerals, in a single serving, packaged within a multi-layer structure foil sachet. Participants will be required to mix Effervescent powder with water before consumption.
The placebo is also an Effervescent powder that is Orange flavored, but without active components, packaged within a multi-layer structure foil sachet. The placebo will be packaged in a manner that it looks and feels just like the micronutrient supplement with the only difference being the absence of the active ingredient in the micronutrient supplement.
The primary outcome of this study is to determine if micronutrient supplement improves the vitamin D status of the study participants with or without additional Nutrition Training and Healthy Lifestyle Coaching (herein referred to as NuTHLiC), Vitamin D status will be assessed as serum 25(OH) D in serum.
The secondary objectives are to:
After consenting, blood samples will be taken for biochemical analyses and the participants will also be assessed through standardized questionnaires in addition to vitals and anthropometric measurements.
The primary analysis will be intention-to-treat analysis. We fit a linear mixed effect model involving a random effect of participants within treatment groups and fixed effects of time and their interactions. The treatment effects will be shown as the mean difference (95% CI) in the change in serum 25(OH)D concentration between intervention and control groups. Model assumptions will be checked by inspecting the residual and quantile-quantile plot. Difference-in-difference (DID) will be used to determine the effect of each micronutrient supplement between the treatment (intervention) groups and the control (placebo) group. Sub-group analysis will also be used to contrast the factorial analysis.
This is the only study on the registry with InnoNext Sarl as lead sponsor.
Counted across the registry records on this site, refreshed daily.
For female participants with childbearing potential:
Exclusion Criteria:
Particiants receive a daily Investigational Product for 24 weeks plus Nutrition Training and Healthy Lifestyle Coaching
Dietary Supplement: Active Effervescent Powder · Other: Nutrition training and healthy lifestyle coaching
Participants receive a daily active Investigational Product for 24 weeks
Dietary Supplement: Active Effervescent Powder
Participants receive a daily placebo Investigational Product for 24 weeks
Dietary Supplement: Placebo Effervescent powder
Participants receive a daily sachet of effervescent powder that is Orange flavored, containing multiple vitamins and minerals
Participants receive a daily sachet of effervescent powder that is Orange flavored containing no active ingredients
Participants receive Nutrition training and healthy lifestyle coaching
Number of participants with improved Vitamin D status
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the vitamin D status of the study participants with or without additional Nutrition Training and Healthy Lifestyle Coaching. Thresholds for determining Vitamin D status are based on serum 25-hydroxyvitamin D levels.
Time frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved vitamin B12 status
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of Vitamin B12 of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time frame: Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved serum zinc status
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of serum zinc of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved serum magnesium status
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of serum magnesium of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time frame: Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants with improved serum ferritin and red blood cell Haemoglobin status
It will be measured with biomarker sampling at baseline, midpoint and endpoint if micronutrient supplementation improves the status of serum ferritin and red blood cell haemoglobin of the study participants that will receive a micronutrient supplement with or without additional Nutrition Training and Healthy Lifestyle Coaching.
Time frame: Time Frame: From baseline to endpoint data collection, the time frame is 24 weeks
Number of participants reporting effectiveness of additional Nutrition Training and Healthy Lifestyle Coaching on their lifestyle habits and overall well-being
The effect of micronutrient supplementation with or without additional Nutrition Training and Healthy Lifestyle Coaching on participants' lifestyle habits and overall well- being will be measured through targeted questionnaires as per outcome 2. The following data collection tools are used: 1) Global physical activity questionnaire; 2) Lifestyles and Habits Questionnaire; 3) Depression Anxiety Stress Scale 21; 4) Short Item Form Survey; 5) Young Women Food Intake; 6) Food Insecurity Experience; 7) 7-day Dietary Habit Recall; 8) Non-alcoholic Sugar-Sweetened Beverage Intake; 9) Multidimensional Subjective Wellbeing (MSW); 10) Nutrition Training and Healthy Lifestyle questionnaire. Each questionnaire has a different scale. Each questionnaire will be evaluated separately...
Time frame: From baseline to endpoint data collection, the time frame is 24 weeks
Plan to share: No — A Data sharing agreement (but not a formal IDP plan) was signed giving access to other researchers for academic, non-commercial purposes. It stipulates: 1. For the sole use of any and all academic, non-commercial research purposes, including communication and publication in scientific journals, the Sponsor grants the Chief Investigator and the Participating Institution a royalty-free, non-exclusive, worldwide, perpetual, non-transferable license to use all Data, suitably anonymized. 2. The Chief Investigator, shall not and shall procure that the Participating Institutions shall not, give access to the Data to any commercial organisation other than the Sponsor and the Supporting Funder during the term of this Agreement and for a period of five years from the date of completion of the Study without the prior written consent of the Sponsor. 3. The Sponsor and the Chief Investigator agree to inform in writing each other about all organisations to whom they grant access to the Data.
No publications or documents are linked to this record.
This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.